Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The second wave of SARS-CoV-2 infections and COVID-19 deaths in Germany – driven by values, social status and migration background? A county-scale explainable machine learning approach

View ORCID ProfileGabriele Doblhammer, View ORCID ProfileConstantin Reinke, View ORCID ProfileDaniel Kreft
doi: https://doi.org/10.1101/2021.04.14.21255474
Gabriele Doblhammer
1University of Rostock
2German Center for Neurodegenerative Diseases, Bonn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gabriele Doblhammer
  • For correspondence: gabriele.doblhammer{at}uni-rostock.de
Constantin Reinke
1University of Rostock
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Constantin Reinke
Daniel Kreft
1University of Rostock
2German Center for Neurodegenerative Diseases, Bonn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Kreft
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

There is a general consensus that SARS-CoV-2 infections and COVID-19 deaths have hit lower social groups the hardest, however, for Germany individual level information on socioeconomic characteristics of infections and deaths does not exist. The aim of this study was to identify the key features explaining SARS-CoV-2 infections and COVID-19 deaths during the upswing of the second wave in Germany.

We considered information on COVID-19 diagnoses and deaths from 1. October to 15. December 2020 on the county-level, differentiating five two-week time periods. We used 155 indicators to characterize counties in nine geographic, social, demographic, and health domains. For each period, we calculated directly age-standardized COVID-19 incidence and death rates on the county level. We trained gradient boosting models to predict the incidence and death rates with the 155 characteristics of the counties for each period. To explore the importance and the direction of the correlation of the regional indicators we used the SHAP procedure. We categorized the top 20 associations identified by the Shapley values into twelve categories depicting the correlation between the feature and the outcome.

We found that counties with low SES were important drivers in the second wave, as were those with high international migration and a high proportion of foreigners and a large nursing home population. During the period of intense exponential increase in infections, the proportion of the population that voted for the Alternative for Germany (AfD) party in the last federal election was among the top characteristics correlated with high incidence and death rates.

We concluded that risky working conditions with reduced opportunities for social distancing and a high chronic disease burden put populations in low-SES counties at higher risk of SARS-CoV-2 infections and COVID-19 deaths. In addition, noncompliance with Corona measures and spill-over effects from neighbouring counties increased the spread of the virus. To further substantiate this finding, we urgently need more data at the individual level.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

No clinical trial

Funding Statement

No external funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No ethics approval was required because of the use of aggregate data.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The following datasets were derived from sources in the public domain: Robert Koch Institute, ESRI. RKI COVID19. dl-de/by-2-0. https://npgeo-corona-npgeo-de.hub.arcgis.com/datasets. Statistical Offices of the Federation and the Laender. Regional database. https://www.regionalstatistik.de/genesis DESTATIS Census 2011: Census database. https://ergebnisse.zensus2011.de INKAR Database: Federal Institute for Research on Building, Urban Affairs, and Spatial Devel-opment. INKAR - Indikatoren und Karten zur Raum- und Stadtentwicklung 2020. https://www.inkar.de/ European Center for Disease Prevention and Control: Download historical data (to 14 De-cember 2020) on the daily number of new reported COVID-19 cases and deaths world-wide (https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide) The following data are available on request from the data holder: Emission data: German Environment Agency Database (UAB): https://www.umweltbundesamt.de/en

https://npgeo-corona-npgeo-de.hub.arcgis.com/datasets.

https://www.regionalstatistik.de/genesis

https://ergebnisse.zensus2011.de

https://www.inkar.de/

https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide

https://www.umweltbundesamt.de/en

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 19, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The second wave of SARS-CoV-2 infections and COVID-19 deaths in Germany – driven by values, social status and migration background? A county-scale explainable machine learning approach
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The second wave of SARS-CoV-2 infections and COVID-19 deaths in Germany – driven by values, social status and migration background? A county-scale explainable machine learning approach
Gabriele Doblhammer, Constantin Reinke, Daniel Kreft
medRxiv 2021.04.14.21255474; doi: https://doi.org/10.1101/2021.04.14.21255474
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The second wave of SARS-CoV-2 infections and COVID-19 deaths in Germany – driven by values, social status and migration background? A county-scale explainable machine learning approach
Gabriele Doblhammer, Constantin Reinke, Daniel Kreft
medRxiv 2021.04.14.21255474; doi: https://doi.org/10.1101/2021.04.14.21255474

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)